Canadian Drug Pricing Reforms Could Lead To Medicine Shortages
Executive Summary
Drug pricing reform in Canada could prompt companies to launch elsewhere or see drugs diverted to the US.
You may also be interested in...
What’s Next? Five Things To Look Out For In July
This month, long-awaited new pricing measures in Canada will come into force, while several trials will either kick off or end, including a liability opioids case involving Teva in San Francisco and Hatch-Waxman litigation over Otsuka/Lundbeck’s Rexulti.
Canada Pulls Controversial Pricing Measures
Some measures aimed at reducing medicine prices in Canada have been dropped, to the relief of the pharmaceutical industry.
COVID-19 Pandemic Means Another Delay For Canadian Pricing Reforms
Industry has have welcomed another delay to the implementation of drug pricing reforms that aim to lower Canadian drugs prices.